1. Home
  2. News
  3. CABIO Biotech (Wuhan) Co. Ltd.
  4. (688089)"Cabio Biotech (Wuhan) Co., Ltd."Report for Q3 2026
More CABIO Biotech (Wuhan) Co. Ltd. news
CABIO Biotech (Wuhan) Co. Ltd.SSE: 688089

(688089)"Cabio Biotech (Wuhan) Co., Ltd."Report for Q3 2026

Oct 30, 2026 · Issued by CABIO Biotech (Wuhan) Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688089 · Oct 30, 2026 · 17 pages · Chinese

On 6ix: 6ix.com/news/688089cabio-biotech-wuhan-co-ltdreport-for-q3-2026

CABIO Biotech (Wuhan) Co. Ltd. on 6ix

Earlier from CABIO Biotech (Wuhan)

  • (688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Resignation of the Securities Affairs RepresentativeOct 17
  • (688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Progress of the Imposition of Other Risk Warning on the Company's SharesSep 30
  • Announcement on Receipt of the Notice of Response to Retrial and Progress of LitigationSep 15
  • Semi-annual Report for 2026Aug 22
  • Announcement on Resignation of Independent DirectorAug 13

Later from CABIO Biotech (Wuhan)

  • (688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Progress of LitigationNov 5
All CABIO Biotech (Wuhan) news releases↗

Follow CABIO Biotech (Wuhan) into a list and get an email when it puts out news.

Follow CABIO Biotech (Wuhan)
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer